Erlonat - 150 Mg Tablets, 30 Tablets Pack | Cancer Cell Inhibitor, Tyrosine Kinase Blocker, Enhanced Treatment For Lung And Pancreatic Cancers

Erlonat is a cancer medication prescribed to patients suffering from lung or pancreatic cancers. It operates by inhibiting a protein associated with cancer cell growth known as tyrosine kinase. This action slows the growth of cancer cells and may prevent their spread to nearby tissues or other areas of the body. Your health care provider may prescribe other medications along with Erlonat to treat your particular condition.
The action mechanism of the medicine is as follows:
Functions by blocking the action of an abnormal protein to slow down the growth of cancer cells
Supplied as:
Available in 25 mg, 100 mg & 150 mg tablets
Specifications
Product Name : Erlonat
Contains : Erlotinib 250mg
Form : Tablet
Strength : 150 mg
Packing : Pack of 30 tablets
Dosage:
This medicine should always be taken with a full glass of water on an empty stomach, at least one hour before or two hours after eating. Swallow the tablets whole without alteration such as crushing, chewing, or dissolving, as this may change the medication's effectiveness or safety. It is also recommended to take your dosage at the same time(s) each day to achieve the maximum effect.

You may be instructed to attend regular appointments with your health care provider to monitor your progress and ensure the correct usage. Be sure to follow all directions closely as it may be necessary to adjust your dosage based on observation.